FDA Drug Recalls

Recalls / Class II

Class IID-0469-2023

Product

Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl oz) bottle, Sterile, Distributed by Medtech Products Inc. Tarrytown, NY 10591, A Prestige Consumer Healthcare company, Made in Israel, UPC 678112000708; NDC 67172-504-01.

Affected lot / code info
Lot #114349, Exp. 05/2023; 117396, Exp. 09/2023; 120128, Exp. 11/2023; 114371, Exp. 06/2023; 123781, Exp. 02/2024.

Why it was recalled

Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

Recalling firm

Firm
Teva Pharmaceuticals USA Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
400 Interpace Pkwy Bldg A, N/A, Parsippany, New Jersey 07054-1120

Distribution

Quantity
715,632 bottles
Distribution pattern
Nationwide in the U.S.A.

Timeline

Recall initiated
2023-02-23
FDA classified
2023-03-20
Posted by FDA
2023-03-22
Terminated
2023-11-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0469-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.